- The Determinants of the Use of Opportunistic Screening Programs in Korea
-
Kang S, You CH, Kwon YD
- KMID: 797674
- J Prev Med Public Health.
- 2009 May;42(3):177-182.
- doi: 10.3961/jpmph.2009.42.3.177
OBJECTIVES: Both organized and opportunistic screening programs have been widely used in Korea. This paper examined the determinants of the use of opportunistic screening programs in Korea. METHODS: The subjects... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors Associated with Cancer Screening Participation, Korea
-
Kwak MS, Park EC, Bang JY, Sung NY, Lee JY, Choi KS
- KMID: 792380
- J Prev Med Public Health.
- 2005 Nov;38(4):473-481.
OBJECTIVES: We wanted to identify those factors associated with stomach, colon, breast and cervix cancer screening. METHODS: A population-based telephone survey was conducted for 2 weeks (the 9th-23th of July,... -
- CITED
-
- Close
- SHARE
-
- Close
- Participation Rate and Related Socio-demographic Factors in the National Cancer Screening Program
-
Sung NY, Park EC, Shin HR, Choi KS
- KMID: 1747575
- J Prev Med Public Health.
- 2005 Feb;38(1):93-100.
BACKGROUND: Cancer is the leading cause of death and one of the largest burdens of disease in Korea. In 1996, the 'Ten year Plan for Cancer Control' was formulated and... -
- CITED
-
- Close
- SHARE
-
- Close
- Trend of Socioeconomic Inequality in Participation in Cervical Cancer Screening among Korean Women
-
Jang SN, Cho SI, Hwang SS, Jung-Choi , Im SY, Lee JA, Kim MK
- KMID: 792529
- J Prev Med Public Health.
- 2007 Nov;40(6):505-511.
- doi: 10.3961/jpmph.2007.40.6.505
OBJECTIVES: While cervical cancer is one of the leading cancers among women worldwide, there are a number of effective early detection tests available. However, the participation rates in cervical... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment Gap in the National Health-screening Program in Korea: Claim-based Follow-up of Statin Use for Sustained Hypercholesterolemia
-
Ahn E, Shin DW, Yang HK, Yun JM, Chun SH, Suh B, Lee H, Son KY, Cho B
- KMID: 2344151
- J Korean Med Sci.
- 2015 Sep;30(9):1266-1272.
- doi: 10.3346/jkms.2015.30.9.1266
Participation in a screening program by itself may not improve clinical outcomes. Treatment gaps in the program may limit its full benefit. We evaluated statin prescription rates for subjects with... -
- CITED
-
- Close
- SHARE
-
- Close
